BerGenBio ASA (BRRGF) has released an update.
BerGenBio ASA, a Norwegian biopharmaceutical firm, will reveal its second quarter and half-year 2024 financial results on August 21, 2024. The announcement will be made during a live webcast from the ‘Vestland på Børs’ conference, with senior management providing a business update. The financial report and presentation will be accessible on the company’s website on the day of the announcement.
For further insights into BRRGF stock, check out TipRanks’ Stock Analysis page.